Markus Thor
Plus aucun poste en cours
Profil
Markus Thor held several positions in the pharmaceutical industry.
He was a Senior Research Scientist at Pharmacia Corp.
from 1994 to 2001.
He then became Vice President of Corporate Development at Biovitrum AB from 2001 to 2009.
After that, he was the Chief Business Officer at iNovacia AB from 2009 to 2013 and at Kancera AB from 2010 to 2013.
In 2019, he briefly served as Head of Business Development at LIDDS AB.
Mr. Thor holds a Master's in Business Administration from Stockholm School of Economics and a graduate degree from Umea Universitet.
Anciens postes connus de Markus Thor
| Sociétés | Poste | Fin |
|---|---|---|
| LIDDS AB | Corporate Officer/Principal | 01/12/2019 |
| KANCERA AB | Corporate Officer/Principal | 01/06/2013 |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Corporate Officer/Principal | 01/05/2013 |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01/08/2009 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Directeur Technique/Scientifique/R&D | 01/08/2001 |
Formation de Markus Thor
| Stockholm School of Economics | Masters Business Admin |
| Umea Universitet | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIDDS AB | Health Technology |
| KANCERA AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
